Palatin Technologies, Inc. (PTNT)
OTCMKTS
· Delayed Price · Currency is USD
0.1424
+0.0022 (1.57%)
At close: Jul 10, 2025
Palatin Technologies Revenue
Palatin Technologies had revenue of $350.00K in the twelve months ending March 31, 2025, down -94.07% year-over-year. In the fiscal year ending June 30, 2024, Palatin Technologies had annual revenue of $4.49M, down -7.49%.
Revenue (ttm)
350.00K
Revenue Growth
-94.07%
P/S Ratio
19.12
Revenue / Employee
11.67K
Employees
30
Market Cap
6.69M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 4.49M | -363.59K | -7.49% |
Jun 30, 2023 | 4.85M | 3.39M | 230.53% |
Jun 30, 2022 | 1.47M | 1.66M | -878.62% |
Jun 30, 2021 | -188.60K | -306.59K | -259.84% |
Jun 30, 2020 | 117.99K | -60.18M | -99.80% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo, Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Glass House Brands | 215.62M |
Elite Pharmaceuticals | 84.04M |
American Oncology Network | 1.76B |
Northwest Biotherapeutics | 1.47M |
Silence Therapeutics | 27.70M |
Palatin Technologies News
- 2 months ago - Palatin Technologies, Inc. (PTN) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Palatin Reports Fiscal Year 2025 Third Quarter Results and Business Update - PRNewsWire
- 2 months ago - Palatin Presents Promising Preclinical Data on Melanocortin Agonists for Retinopathy at ARVO 2025 - PRNewsWire
- 2 months ago - Palatin Technologies Announces Closing of Reduced Public Offering - PRNewsWire
- 2 months ago - Palatin Technologies Announces Transition to OTC Pink Following NYSE American Delisting Notice - PRNewsWire